Validation of an HPLC-UV method for the determination of ceftriaxone sodium residues on stainless steel surface of pharmaceutical manufacturing equipments

被引:35
作者
Akl, Magda A. [1 ]
Ahmed, Mona A. [2 ]
Ramadan, Ahmed [1 ]
机构
[1] Mansoura Univ, Fac Sci, Dept Chem, Mansoura, Egypt
[2] Ain Shams Univ, Dept Chem, Coll Girls, Cairo, Egypt
关键词
Ceftriaxone sodium; HPLC-UV; Cleaning validation; Residues; Swab analysis; LIQUID-CHROMATOGRAPHIC METHOD; ASSAY; PLASMA; LC;
D O I
10.1016/j.jpba.2011.01.020
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
In pharmaceutical industry, an important step consists in the removal of possible drug residues from the involved equipments and areas. The cleaning procedures must be validated and methods to determine trace amounts of drugs have, therefore, to be considered with special attention. An HPLC-UV method for the determination of ceftriaxone sodium residues on stainless steel surface was developed and validated in order to control a cleaning procedure. Cotton swabs, moistened with extraction solution (50% water and 50% mobile phase), were used to remove any residues of drugs from stainless steel surfaces, and give recoveries of 91.12, 93.8 and 98.7% for three concentration levels. The precision of the results, reported as the relative standard deviation (RSD), were below 1.5%. The method was validated over a concentration range of 1.15-6.92 mu g ml(-1). Low quantities of drug residues were determined by HPLC-UV using a Hypersil ODS 5 mu m (250 x 4.6 mm) at 50 degrees C with an acetonitrile:water:pH 7:pH 5(39-55-5.5-0.5) mobile phase at flow rate of 1.5 ml min(-1), an injection volume of 20 mu l and were detected at 254 nm. A simple, selective and sensitive HPLC-UV assay for the determination of ceftriaxone sodium residues on stainless steel surfaces was developed, validated and applied. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:247 / 252
页数:6
相关论文
共 23 条
[1]   Sensitive assay for the determination of cefazolin or ceftriaxone in plasma utilizing LC [J].
Al-Rawithi, S ;
Hussein, R ;
Raines, DA ;
AlShowaier, I ;
Kurdi, W .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2000, 22 (02) :281-286
[2]  
[Anonymous], 1994, ICH HARM TRIP GUID Q
[3]  
[Anonymous], 1993, GRIZZLY BEAR RECOVER, P1
[4]   DETERMINATION OF CEFTRIAXONE, A NOVEL CEPHALOSPORIN, IN PLASMA, URINE AND SALIVA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ON AN NH2 BONDED-PHASE COLUMN [J].
ASCALONE, V ;
DALBO, L .
JOURNAL OF CHROMATOGRAPHY, 1983, 273 (02) :357-366
[5]  
Boca B., 2005, J PHARM BIOMED ANAL, V37, P461
[6]   REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD TO DETERMINE CEFTRIAXONE IN BIOLOGICAL-FLUIDS [J].
BOWMAN, DB ;
ARAVIND, MK ;
MICELI, JN ;
KAUFFMAN, RE .
JOURNAL OF CHROMATOGRAPHY, 1984, 309 (01) :209-213
[7]  
Budavari S., 2001, The Merck index, V13th, P335
[8]  
Deyi Z., 2006, ANAL SCI, V22, P183
[9]   HPTLC determination of ceftriaxone, cefixime and cefotaxime in dosage forms [J].
Eric-Jovanovic, S ;
Agbaba, D ;
Zivanov-Stakic, D ;
Vladimirov, S .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1998, 18 (4-5) :893-898
[10]   Quantitative determination and sampling of azathioprine residues for cleaning validation in production area [J].
Fazio, Tatiana Tatit ;
Singh, Anil Kumar ;
Kedor-Hackmann, Erika Rosa Maria ;
Rocha Miritello Santoro, Maria Ines .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2007, 43 (04) :1495-1498